Wu et al. showed that in patients with pneumonia from COVID-19, the treatment with simultaneous intake of nine probiotic strains of Lactobacilli led to improved clinical outcomes and lower levels of inflammatory biomarkers (TNF-α, interleukin IL-1β) [23]. The gene discussed is TNF; the disease is susceptibility to pneumonia measurement.